Advancing Feline Diabetes Care: A Caregiver’s Urgent Call for Innovation and Enhanced Support

Published on March 19, 2026, a poignant reflection from Katia Colitti, a Ukrainian-American lawyer and dedicated feline advocate, sheds critical light on the persistent challenges in managing feline diabetes, drawing from her personal four-year journey caring for her beloved cat, Mosi, who was diagnosed at age 17. Colitti’s experience, culminating in Mosi’s passing at 21, underscores a pressing need for significant advancements in veterinary medicine, particularly in glucose monitoring, insulin administration, and comprehensive veterinary guidance. Her narrative serves as a powerful testament to the emotional and practical difficulties faced by countless caregivers of diabetic felines, advocating for a future where such care is less stressful, more effective, and readily supported by tailored technological solutions and consistent professional advice.

Feline diabetes mellitus, a metabolic disorder characterized by high blood glucose levels due to insufficient insulin production or utilization, affects a significant portion of the global cat population. Estimates suggest that between 1 in 200 and 1 in 500 cats may develop diabetes, with the incidence rising, particularly among older, overweight, and less active felines. As veterinary medicine progresses and cats live longer, the prevalence of chronic conditions like diabetes is expected to increase, making the issues highlighted by Colitti more critical than ever. The daily management of this disease, involving strict dietary control, regular insulin injections, and meticulous glucose monitoring, places a substantial burden on pet owners, often leading to caregiver burnout and, in some unfortunate cases, euthanasia due to perceived inability to cope. Colitti’s candid account reveals the intricacies of this daily struggle, proposing three key areas ripe for transformative change.

The Agonizing Ordeal of Glucose Monitoring: A Call for Feline-Specific Technology

One of the most profound struggles Colitti detailed was the "excruciatingly difficult" process of glucose monitoring. Traditional methods, requiring blood samples from a cat’s ears or toes, are fraught with challenges. Colitti recounted her discomfort with using large-gauge needles for toe sampling, a necessity when standard human finger-prick devices are inadequate for the delicate vascular structures of a cat’s paw. Ear sampling, while generally considered "easier," is a relative term in this context. It demands a calm, cooperative cat, precise warming of the ear to encourage blood flow without causing excessive bleeding, the careful application of Vaseline to prevent blood from dispersing into fur, and a meticulous prick near a vein—all while ensuring the cat remains still enough for the blood drop to be quickly transferred to a measuring strip before clotting.

Colitti’s frustration was palpable, detailing instances where multiple pricks were required, samples were insufficient, or too much blood was drawn, causing Mosi distress. This repetitive trauma led to scarring on Mosi’s ears, and in a devastating incident toward the end of her life, an accidental vein strike resulted in severe damage, ultimately leading to necrosis and the loss of the ear tip. Such experiences highlight not only the physical toll on the animal but also the profound emotional distress inflicted upon caregivers, who are forced to inflict pain in an attempt to provide care. "I wanted to help her. I didn’t want to hurt her," Colitti lamented, encapsulating the pervasive guilt and helplessness many owners feel. Studies on caregiver burden in chronic pet illness consistently show elevated stress levels, anxiety, and even depression, underscoring the urgency of simplifying such demanding procedures.

The advent of Continuous Glucose Monitors (CGMs) for humans offered a glimmer of hope, promising to revolutionize feline diabetes management by providing real-time, uninterrupted glucose data without the need for frequent blood draws. These devices, typically small sensors inserted under the skin, measure interstitial fluid glucose levels and transmit data wirelessly to a reader or smartphone. For humans, CGMs have dramatically improved diabetes control, reduced hypoglycemia incidents, and enhanced quality of life. Veterinary professionals have increasingly explored the off-label use of human CGMs in animals, particularly in dogs and cats. However, as Colitti discovered, this application is far from perfect for felines. She tried three such monitors on Mosi, encountering activation failures, premature cessation of function, and significant stress during application and removal. Each attempt required shaving a patch of Mosi’s fragile skin, applying surgical glue, and then a stressful removal process. Mosi’s arthritis further compounded the issue, as the protective shirts used to secure the devices restricted her already limited movement.

Colitti’s experience with CGMs underscores a critical gap in veterinary technology. The ideal feline CGM, she argues, must be "designed specifically for cats: tailored to feline body morphology, smaller, lighter, and gentle enough for thin or elderly cats." Crucially, such devices should be "easy to apply and remove at home" and "work reliably." The current reliance on adapting human technology, while a necessary interim step, fails to account for the unique anatomical, physiological, and behavioral characteristics of felines. Cats have thinner, more delicate skin, are highly sensitive to foreign objects, and often react poorly to invasive procedures, making off-label human CGMs less practical and often counterproductive for long-term home use. Researchers at institutions like the Cummings School of Veterinary Medicine at Tufts University and other animal health innovation centers are actively pursuing solutions, focusing on miniaturization, enhanced biocompatibility, and user-friendly application methods suitable for companion animals. The goal is to develop devices that minimize stress for the animal and maximize data accuracy for the clinician, ultimately leading to better outcomes and reduced caregiver burden.

Beyond CGMs, Colitti also highlighted the need for improved cat-specific glucometers. Initially, she used a human device recommended by her veterinarians, mirroring the clinic’s practice. However, she later learned that feline physiology, particularly differences in red blood cell glucose metabolism and hematocrit levels, can lead to inaccurate readings with human-calibrated meters. While animal-calibrated meters exist, Colitti found their scale and instructions confusing, leading her to return one. This seemingly minor detail reveals a broader issue: the lack of intuitive, cat-specific tools that empower caregivers without requiring them to become technical experts. The call for reliable, user-friendly, cat-specific glucometers is not merely a convenience but a fundamental requirement for accurate dosing and effective disease management, ensuring that "managing feline diabetes should not feel like a constant technical experiment."

Optimizing Insulin Administration: Addressing the Nuances of Feline Injections

Insulin administration, the cornerstone of feline diabetes treatment, also presented a unique set of challenges for Colitti and Mosi. Initially, they established a manageable routine, but complications arose over time. A key recommendation in diabetes care is to rotate injection sites to prevent lipodystrophy (fat atrophy or hypertrophy) and improve insulin absorption. However, Mosi exhibited discomfort in various areas, limiting Colitti’s ability to alternate sites effectively. This highlights the individuality of patient response and the need for flexible, personalized guidance from veterinary professionals who understand that textbook recommendations may not always apply to every animal.

The introduction of insulin pens, a common and often preferred method for human diabetics due to their ease of use and precise dosing, proved unsuitable for Mosi. The pens typically produce an audible "clicking" noise during injection, which, due to Mosi’s auditory disorder, triggered seizures. This unforeseen obstacle immediately rendered the option unviable, underscoring the importance of considering a cat’s specific health conditions and sensitivities when recommending treatment modalities. The incident serves as a poignant reminder that one-size-fits-all solutions rarely apply in complex medical scenarios, particularly with animals who cannot verbally communicate their discomfort or unique needs. Veterinary device manufacturers are increasingly being urged to consider sensory impacts, such as noise levels, in their design processes for animal-specific medical equipment.

The most significant injection challenge emerged in Mosi’s final year, as she experienced substantial weight loss. With reduced subcutaneous fat, accidentally injecting insulin into her fur rather than beneath the skin became a frequent occurrence. Standard veterinary advice rigidly dictates against re-injecting in such cases, fearing the potentially fatal consequences of hypoglycemia (dangerously low blood sugar) if some insulin had indeed been delivered. Colitti adhered to this guidance, even when "nearly certain the dose had not been delivered," a decision she retrospectively questioned. This dilemma—the fear of underdosing leading to hyperglycemia versus the terror of overdosing leading to life-threatening hypoglycemia—is a common and agonizing experience for caregivers of frail diabetic pets. It emphasizes the need for clearer, nuanced guidelines that acknowledge the practical realities of caring for a severely emaciated animal. This could include risk assessment frameworks developed by veterinary endocrinologists, allowing caregivers to make more informed decisions in ambiguous situations, potentially under remote veterinary supervision.

Colitti’s search for instructional videos on injecting thin cats proved largely futile, as most demonstrated techniques on cats of "average weight with generous skin folds," offering little practical help for Mosi’s specific condition. Ultimately, the solution involved shaving the area between Mosi’s shoulder blades, creating a visible target area that ensured reliable insulin delivery. This simple yet critical adaptation, discovered through trial and error, highlights the gap between idealized instructional content and the realities of advanced-stage chronic illness.

Colitti’s recommendations are clear: "We need better, quieter injection pens designed for feline use." Such pens would reduce stress for sensitive cats and simplify the injection process. Furthermore, there is an urgent need for "clear, practical guidance for injecting thin or frail cats, not just easy, perfect examples." This guidance should acknowledge that "real cats age. Real cats lose weight," and care instructions must "reflect that reality." Developing specialized instructional materials, perhaps leveraging veterinary telemedicine platforms for personalized demonstrations, could significantly alleviate caregiver anxiety and improve injection efficacy.

Elevating Veterinary Guidance and Caregiver Education

Despite regular appointments at a "large, reputable clinic," including consultations with a diabetes specialist, Colitti frequently felt a significant deficit in guidance. This experience, unfortunately, is not uncommon among owners managing complex chronic conditions in their pets. The initial diagnosis of feline diabetes is often overwhelming, accompanied by a deluge of information that can be difficult to absorb and retain, especially during an emotionally charged time.

Colitti cited several instances of inconsistent or missing information. At Mosi’s initial appointment, she was advised to reuse syringes twice—a practice she followed for years before growing concerned about insulin contamination. Later research revealed conflicting advice on needle reuse, highlighting a lack of standardized, evidence-based recommendations across the veterinary profession. Important practical details, such as holding the needle bevel-side up for smoother insertion and reduced discomfort, or the critical instruction to discard insulin vials after 20 days, were discovered through online research or meticulous reading of tiny print on medication labels, rather than through direct veterinary guidance. This piecemeal acquisition of vital information creates anxiety and can lead to suboptimal care.

Perhaps most critically, Colitti lamented learning "too late that early, tightly regulated treatment in the first months after diagnosis can sometimes lead to remission in cats." Feline diabetic remission, a state where a cat no longer requires exogenous insulin and maintains normal blood glucose levels, is a highly desirable outcome, achievable in a significant percentage of newly diagnosed cases, particularly if treatment is initiated aggressively and consistently. The window for achieving remission is often narrow, typically within the first few months post-diagnosis. Missing this crucial information deprives caregivers and their pets of a potentially life-altering opportunity, reinforcing the need for comprehensive and timely education at the point of diagnosis. Veterinary endocrinology specialists consistently emphasize the importance of this "golden window" for remission, urging immediate and intensive management strategies.

Colitti, by her own admission, was a "dedicated, proactive, and well-resourced caregiver," seeking frequent help, including regular clinic visits, home visits, and emergency care. Yet, she "often felt that Mosi and I were alone in our fight against diabetes." This sense of isolation, even within a supportive veterinary framework, speaks volumes about the emotional burden of chronic pet illness and the need for more integrated, continuous support systems. The human-animal bond is profoundly strong, and caregivers invest deeply in their pets’ well-being, making this feeling of isolation particularly acute.

To improve this critical aspect of care, Colitti advocates for "clearer, more comprehensive information at diagnosis and more through structured follow-ups." This could involve standardized educational packets, dedicated consultation time, and perhaps even workshops for new diabetic pet owners. Furthermore, for the extensive care required for chronic conditions, clinics could implement "video consultations or subscription-style access to a veterinarian or veterinary nurse for ongoing support." Such models, already gaining traction in human healthcare, offer real-time, tailored guidance, reducing the need for stressful in-person visits for routine queries and providing a vital lifeline for caregivers navigating complex medical regimens. The American Veterinary Medical Association (AVMA) has increasingly recognized and supported the role of telemedicine in enhancing chronic disease management for pets.

Broader Implications and the Path Forward

Katia Colitti’s impassioned plea for improved feline diabetes care extends beyond her personal experience; it resonates with a growing global community of pet owners committed to providing the best possible quality of life for their companions. The issues she raises—technological gaps, inadequate educational resources, and fragmented support—are systemic challenges that impact veterinary medicine broadly. Addressing them would not only alleviate the suffering of diabetic cats and their caregivers but also set a precedent for managing other chronic conditions in companion animals, from chronic kidney disease to arthritis and hyperthyroidism.

The implications of these advancements are far-reaching. Enhanced glucose monitoring, particularly through reliable feline-specific CGMs, would lead to more precise insulin dosing, better glycemic control, and a significant reduction in the risks of both hyperglycemia (high blood sugar, leading to long-term complications) and hypoglycemia (low blood sugar, which can be immediately life-threatening). Quieter, cat-friendly insulin pens and clearer injection guidelines would reduce stress for both cats and owners, potentially improving treatment adherence and overall well-being. Moreover, improved veterinary education and support systems would empower caregivers, foster stronger human-animal bonds, and ensure that pets receive optimal, evidence-based care throughout their illness.

The financial burden associated with chronic illness management is also a significant concern for many families. While Colitti acknowledges her resources, many others struggle. More efficient and less stressful care could indirectly lead to cost savings by reducing emergency visits, simplifying home care, and potentially increasing remission rates, thus decreasing the long-term need for insulin. This could, in turn, make long-term care for diabetic cats more accessible to a wider demographic of pet owners, preventing difficult decisions about a pet’s future.

Colitti concludes with a hopeful note, expressing her desire for continued improvement in feline diabetes care through research and education, specifically highlighting the crucial role of organizations like the EveryCat Health Foundation. Non-profit foundations are often at the forefront of funding studies that may not attract significant commercial investment but are vital for advancing animal health. The "Springing into Action" campaign and the O’Malley Fund for Diabetes and Endocrinopathies, supported by EveryCat Health Foundation, represent concrete pathways for individuals to contribute to this essential research.

Katia Colitti, with her unique background as a lawyer with an MSc in International Animal Welfare, Ethics, and Law, and extensive experience in caring for geriatric and diabetic cats, is uniquely positioned as an informed advocate for these changes. Her voice, grounded in both personal hardship and academic insight, provides a compelling argument for a concerted effort from researchers, veterinary professionals, pharmaceutical companies, and pet owners alike. Together, through sustained funding, innovative research, and a commitment to comprehensive caregiver support, the vision of significantly improved lives for diabetic cats and their dedicated caretakers can become a reality. The advancements she champions are not luxuries but "practical necessities," promising a future where managing feline diabetes is less about struggle and more about compassionate, effective care.